NOOSPHERE

Fichas públicas de documentos

Referencias bibliográficas de procedencia pública y con enlaces estables. El catálogo no incluye todos los documentos del corpus ni reproduce sus textos completos.

98,186 fichas públicas · página 44 / 982

  1. LSD-DETR: A Lightweight Transformer-Based Detector for Sewer-Pipeline Defects in Forward-Looking Sonar Images2026 · Crossref
  2. LSD-UnfoldNet: A Deep Unfolded Network with Learnable Sparse Dictionary for Near-Field Channel Estimation in Massive MIMO Systems2026 · Crossref
  3. LSD-YOLO: A Lightweight Multi-Scale Fusion Network for Railway Insulator Defect Detection2026 · Crossref
  4. Lumbar spine disorder detection using segmentation and IBN-MGNet classification with enhanced feature extraction.2026 · PubMed
  5. Lysergic acid diethylamide pretreatment prolongs brain-stimulation induced neural activity changes.2026 · PubMed
  6. M3 muscarinic receptor antagonism attenuates cocaine-induced hippocampal oligodendroglial changes and relapse-like behavior in male mice.2026 · PubMed
  7. Machine learning combined with fMRI identifies dynamic brain network alterations in post-stroke depression: A dual-center cross-sectional study.2026 · PubMed
  8. Machine learning in forensic toxicology: Concepts, applications and challenges in bioanalysis, ADME, and toxicodynamics.2026 · PubMed
  9. Machine learning models to detect opioid misuse in emergency department patients at triage.2026 · PubMed
  10. Machine learning recovers folk classification of <i>Banisteriopsis caapi</i> from herbarium leaves an ayahuasca liana.2026 · PubMed
  11. Machine Learning, Supervised Leveraging Supervised Machine Learning to Improve Accuracy in Predicting Smartphone Addiction2026 · Crossref
  12. Machine learning-ready genomic biomarkers: ATF3 polymorphisms predict postoperative analgesic demand through AI-compatible phenotyping.2026 · PubMed
  13. Macroscopic T-Wave Alternans in QTc Prolongation: A Warning Sign Before Torsades de Pointes.2026 · PubMed
  14. Mad honey poisoning in Nepal: ecology, epidemiology, and clinical spectrum of grayanotoxin intoxication (2009-2026).2026 · PubMed
  15. Magnetic graphene-imine-linked covalent organic polymer composites for fast extraction and UPLC-MS/MS quantification of 14 trace drugs of abuse and their metabolites in wastewater.2026 · PubMed
  16. magnetismo del peyote2026 · Crossref
  17. Magnetite-facilitated AHL-mediated quorum sensing enhances nitrate removal and mitigates nitrous oxide emissions in constructed wetlands under polycyclic aromatic hydrocarbons stress.2026 · PubMed
  18. Magnitude and Burden of Substance Use Disorders Among Adolescents in Eastern Sub-Saharan Africa: Regional Analysis From Global Burden of Diseases 1990 to 20232026 · Crossref
  19. Magnitude of response in treatment and control groups within psychedelic trials for psychiatric disorders: A meta-analysis.2026 · PubMed
  20. Maintained Symptom Control Following a Shortage-Driven Switch to Immediate-Release Dextroamphetamine: A Case Report.2026 · PubMed
  21. Maintaining IV Patency Throughout Pharmacokinetic Studies Through a Needle-Free Blood Draw Device.2026 · PubMed
  22. Major depressive disorder-alcohol use disorder comorbidity: diagnosis, mechanisms and treatment.2026 · PubMed
  23. Major in vitro phase I and phase II metabolites of cannabichromene2026 · Crossref
  24. Major life changes following psychedelic use: A retrospective survey among people using psychedelics naturalistically.2026 · PubMed
  25. Making 'safer injecting' matter for people who inject image and performance enhancing drugs.2026 · PubMed
  26. Making a case for using MDMA-assisted psychotherapy for borderline personality disorder and complex PTSD: a descriptive systematic review of the literature.2026 · PubMed
  27. Making up people involved in drug markets: Punishment and protection in the policing of UK county lines2026 · Crossref
  28. Making Veterans Visible in Australia's Alcohol and Other Drug Services: Leveraging the Alcohol and Other Drug National Quality Framework2026 · Crossref
  29. Maladaptive Daydreaming in a Psychiatry Outpatient Clinic: The Associations with Dissociation, Childhood Trauma and Emotional Dysregulation2026 · Crossref
  30. MALADAPTIVE DAYDREAMING: A SYNDROME AT THE INTERSECTION OF ATTENTIONAL DYSFUNCTION AND BEHAVIORAL COMPULSION2026 · Crossref
  31. Maladaptive personality traits and their relations with online behavior: an instagram-based study2026 · Crossref
  32. Malic Enzyme 1 Limits Acetaminophen-Induced Liver Injury by Sustaining Redox and Bioenergetic Homeostasis2026 · Crossref
  33. Malicious poisoning of a canine with the neuromuscular blocking agent rocuronium: a case report with postmortem quantitation2026 · Crossref
  34. MANAGEMENT AND OBTAINING INFORMED CONSENT COMPLICATED BY INTELLECTUAL DISABILITY IN A PATIENT WITH MRKH SYNDROME - A CASE REPORT2026 · Crossref
  35. Management of a Kratom and Tianeptine Overdose.2026 · PubMed
  36. Management of Acute Liver Failure Due to Drug–Drug Interactions Using a Novel Nutraceutical: A Case Report2026 · Crossref
  37. Management of acute withdrawal from 7-hydroxymitragynine after high-dose chronic use: A case report2026 · OpenAlex
  38. Management of depression utilizing Traditional Chinese Medicine2026 · OpenAlex
  39. Management of emergencies related to cannabis, its derivatives, and synthetic cannabinoids: an update2026 · Crossref
  40. Management of Neuropathic Pain in Complex Regional Pain Syndrome: A Comprehensive Review.2026 · PubMed
  41. Management of Opioid Use Disorder Caused by Use of Weak Herbal Opiates in an Immigrant Panjabi Man2026 · Crossref
  42. Management of Opioid Withdrawal Syndrome and Commencement of Opioid Dependence Treatment Following Chronic Use of a Vaping Product Containing Protonitazene: Case Report2026 · OpenAlex
  43. Managing 7-Hydroxymitragynine Use Disorder with Buprenorphine-Naloxone2026 · OpenAlex
  44. Managing benzodiazepine dependence arising from use of the adulterated opioid supply: a commentary2026 · Crossref
  45. Managing Cancer-Related Pain in Patients Receiving Long-Acting Buprenorphine for Opioid Use Disorder.2026 · PubMed
  46. Managing controlled substances in ambulatory practice2026 · Crossref
  47. Managing Legacy Opioid Patients, Patients with Comorbid Substance Use, and a Role for Buprenorphine for Pain.2026 · PubMed
  48. Managing the Complex Intersection Between Substance Use Disorders and Infectious Diseases2026 · Crossref
  49. MANDADO DE INJUNÇÃO NÃO SUBSTITUI POLÍTICA PÚBLICA: OS LIMITES DO JUDICIÁRIO FIXADOS PELO STJ NO CASO DO CULTIVO DOMÉSTICO DE CANNABIS MEDICINAL2026 · Crossref
  50. Mangrove-Derived Phytochemicals: Therapeutic Role in Depression and Hypertension Management2026 · Crossref
  51. Manifestation of Drinking Profiles in Daily Life: Associations With Momentary Negative Affect, Impulsivity, and Drinking2026 · Crossref
  52. Manipulating the Gibberellin Pathway Alters Harvest Index and Cannabinoid Content in Cannabis sativa L.2026 · PubMed
  53. Many teens not aware of fentanyl use risk2026 · Crossref
  54. Mapping and measuring addiction recovery: Recommended protocols through the PHENX toolkit.2026 · PubMed
  55. Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics.2026 · PubMed
  56. Mapping DNA Methylation Signatures to Identify Epigenetic Variation Across Subcortical Regions of the Human Posttraumatic Stress Disorder Brain.2026 · PubMed
  57. Mapping needles, reducing harm: Findings from a geospatial, community-based needle collection and naloxone training initiative in Saskatchewan, Canada2026 · Crossref
  58. Mapping Non-Prescription Pre-Session Support across Psychedelic Substances2026 · OpenAlex
  59. Mapping of Tobacco Harm Reduction in Pakistan: An Alternative Option for Smoking Cessation Policies2026 · Crossref
  60. Mapping Soil Organic Carbon Stock Using Multisource Remote Sensing Indicators in Khat (Catha edulis)-Dominated Landscapes of Eastern Ethiopia2026 · Crossref
  61. Mapping the Evidence on Kratom Use, Health Outcomes, and Policy Gaps in the United States: A Scoping Review.2026 · PubMed
  62. Mapping the flavoring landscape: a comparative analysis of tobacco and related products2026 · Crossref
  63. Mapping the Intervention Landscape for Methamphetamine Use Disorder: A Scoping Review of Integrated Pharmacological, Behavioral, and Neuromodulation Approaches2026 · Crossref
  64. Mapping the research landscape of minor cannabinoids: a bibliometric analysis of research trends and hotspots2026 · Crossref
  65. Mapping the subjective importance of the topic ‘parenthood’ for parents with substance use disorder in inpatient rehabilitative care – an explorative qualitative study in Germany2026 · Crossref
  66. Marijuana Legalization and Suicides Among Older Adults2026 · Crossref
  67. Marijuana use and its association with unhealthy weight control and muscle-enhancing behaviors among sexual minority men in the United States: a cross-sectional analysis2026 · Crossref
  68. Marijuana Use by College Students: Relationships With Personality Traits and Protective Factors of Resilience2026 · Crossref
  69. Marijuana Use for Symptom Control in Inflammatory Bowel Disease: Patients’ Perceptions and Patterns of Use2026 · Crossref
  70. Market approval and the right to health: a human rights perspective on MDMA-assisted therapy2026 · Crossref
  71. Marketing Communication Strategy of Coffee Shop “1994 Coffee and Creative Space Bandung” in Increasing Customer Loyalty2026 · Crossref
  72. Marketing Global2026 · Crossref
  73. Marketing Strategy in Building Brand Image of New Coffee Shop2026 · Crossref
  74. Material Deprivation, Psychological Distress, and Substance Use Among Socioeconomically Disadvantaged Adolescents: The Mediating Roles of Social Relationships2026 · Crossref
  75. Maternal childhood adversity as an upstream vulnerability for prenatal alcohol use and maternal mental health.2026 · PubMed
  76. Maternal control during prenatal oxycodone exposure: differential effects of voluntary versus involuntary self-administration on offspring substance use vulnerability in rats.2026 · PubMed
  77. Maternal immune activation in mice recapitulates features of attention-deficit/hyperactivity disorder (ADHD) in susceptible offspring.2026 · PubMed
  78. Matrix-dependent analytical strategies for the detection of drug-infused foods: A comprehensive review.2026 · PubMed
  79. Matters arising: Methodological concerns and interpretative limitations of assessing subjective effects of ketamine.2026 · PubMed
  80. Maturing out or in? Demographic determinants of young adult drinking trajectories and midlife alcohol use disorder risks2026 · Crossref
  81. MDMA administration reduces ethanol drinking and is associated with altered nociceptin and dynorphin system gene expression in alcohol-preferring rats.2026 · PubMed
  82. MDMA alters fear extinction, and reduces alcohol consumption in inbred alcohol preferring iP rats but not outbred Wistar rats.2026 · PubMed
  83. MDMA and Psilocybin Regulate Oligodendrocyte-Lineage Cell Numbers and Anxiety-Like Behaviors in a Rat Model of Fear.2026 · PubMed
  84. MDMA as an early post-trauma intervention in a translational animal model of PTSD.2026 · PubMed
  85. MDMA-Assisted Psychotherapy for Cluster B Personality Disorders: A Narrative Review of This Translational Framework for Relational Healing2026 · Crossref
  86. MDMA-assisted PTSD and Alcohol Therapy Trial (MPATHY): study protocol for a double-blind, randomised, controlled outpatient trial of MDMA-assisted integrated exposure-based therapy for comorbid post-traumatic stress disorder and alcohol use disorder.2026 · PubMed
  87. MDMA-assisted therapy for major depressive disorder: A seven-month follow-up proof of principle trial.2026 · PubMed
  88. MDMA-Assisted Therapy for PTSD: Neuroplastic Change or Psychotherapeutic Catalyst?2026 · Crossref
  89. MDMA-Assisted Therapy May Decrease PTSD Symptoms, Dissociation, Depression, and Functional Disability: A Systematic Review and Meta-Analysis.2026 · PubMed
  90. MDMA-Assisted Treatment for PTSD, Anxiety, and Depression: A Visualized Literature Analysis over 30 Years2026 · Crossref
  91. MDMA-induced CYP2D6 inhibition: concentration-dependent variability using dextromethorphan as a probe.2026 · PubMed
  92. Me, myself, and high: precipitants of emerging adult solitary cannabis use.2026 · PubMed
  93. Meaning in Life, Substance Use Severity, and Depressive Symptoms in Adolescents with Substance Use Disorder2026 · Crossref
  94. Meaning-Centered Psychotherapy for Psilocybin-Assisted Therapy Among Patients with Advanced Cancer and Depression: Rationale and Preliminary Evaluation of MCP-PSIL.2026 · PubMed
  95. Measurement uncertainty in urine drug analysis: A comparison of ISO/TS 20914 and GUM/Eurachem approaches.2026 · PubMed
  96. Measures of recovery used in clinical settings among people with opioid use disorder: a rapid review of the literature2026 · Crossref
  97. Measuring the psychoactive effects of ketamine in alcohol use disorder: When assessment shapes experience2026 · OpenAlex
  98. Measuring the Reflective Self and Experiential Self in Self-Transcendent Experiences2026 · OpenAlex
  99. Mechanism Design for Harm Reduction: Game Theory and Social Choice for Carceral MOUD and Recovery Housing2026 · Crossref
  100. Mechanism of Ketosis and Seizure Control in Pediatric Drug-Resistant Epilepsy: Insights from an Indianized Ketogenic Diet2026 · Crossref